<DOC>
	<DOCNO>NCT00387686</DOCNO>
	<brief_summary>The primary objective study ass whether single dose rhBMP-2/CPM administered fracture site via percutaneous injection , combination standard care , accelerate fracture union return normal function subject close diaphyseal tibial fracture compare standard care alone .</brief_summary>
	<brief_title>A Phase 2/3 Multicenter , Controlled Trial Of rhBMP-2/CPM In Tibial Fractures</brief_title>
	<detailed_description />
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Tibial Fractures</mesh_term>
	<criteria>Skeletally mature , male female subject least 18 year old . Closed diaphyseal tibial fracture . Closed reduction definitive internal fixation mean ream , lock intramedullary nail within 72 hour injury . Concurrent fracture ipsilateral contralateral low extremity ipsilateral fibula , would impede performance functional assessment weight bearing . Planned procedure ( ) stimulate fracture heal intramedullary nailing . Neurovascular impairment fracture limb , deep vein thrombosis , ( impend ) compartment syndrome .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>